Fintel reports that on February 28, 2025, Goldman Sachs initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy ...

Pharmaceutical company Summit Therapeutics is standing out today, surging to $20.45 and marking a 10.6% change. In comparison ...

This decline is attributed to weakness in key markets, including the EU, China, and the UK, coupled with planned model changeovers affecting production schedules.

With the UK buying nearly 100,000 Chinese cars in 2024, a motoring expert has shared how the country has become the world's ...

Monday (March 3): High Court hears Jes Staley case over FCA ban; Covid inquiry begins hearings into procurement; Mobile World ...

Why do we love dogs? Dogs evolved from wolves but why did they choose us humans to be their best friends? 10 Places You Didn’t Know Were Connected to King Arthur King Arthur is linked to several ...

Piper Sandler analyst Yasmeen Rahimi initiated coverage on Avalo Therapeutics, Inc. AVTX with an Overweight rating and ...